Burkett Financial Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$65.1K Buy
+403
New +$67.2K 0.02% 118
2026
Q1
– Sell
-37
Closed -$6.85K – 250
2025
Q4
$6.85K Hold
37
– – ﹤0.01% 172
2025
Q3
$5.71K Sell
37
-1
-3% -$151 ﹤0.01% 169
2025
Q2
$5.24K Hold
38
– – ﹤0.01% 167
2025
Q1
$5.51K Buy
+38
New +$5.5K ﹤0.01% 183

Other funds holding AZN

Burkett Financial Services's AZN Position: Q3 2026 in Review

Burkett Financial Services opened a new position in AstraZeneca (AZN) in Q3 2026: 403 shares worth $65.1K. The stake represents 0.02% of the portfolio and ranks #118 among its holdings. This is a return to the name: Burkett Financial Services previously reported a position in AZN as recently as Q4 2025.

Burkett Financial Services first reported a position in AZN in Q1 2025 and has held it in 5 quarters since. 47 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Burkett Financial Services held 403 shares of AstraZeneca worth $65.1K as of Q3 2026.
  • AstraZeneca was a new Burkett Financial Services position in Q3 2026.
  • AstraZeneca made up 0.02% of Burkett Financial Services's portfolio in Q3 2026, its #118 holding.
  • Burkett Financial Services first reported a position in AstraZeneca in Q1 2025 and has held it in 5 quarters since.
  • 47 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Burkett Financial Services's 13F filing for Q3 2026, filed 1 Oct 2026.